Total Payments
$69,973
2024 Payments
$1,275
Companies
72
Transactions
489
Medicare Patients
2,778
Medicare Billing
$298,859
Payment Breakdown by Category
Other$30,537 (43.6%)
Research$15,006 (21.4%)
Food & Beverage$10,525 (15.0%)
Travel$7,881 (11.3%)
Consulting$6,025 (8.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $25,496 | 19 | 36.4% |
| Unspecified | $15,006 | 10 | 21.4% |
| Food and Beverage | $10,525 | 426 | 15.0% |
| Travel and Lodging | $7,881 | 29 | 11.3% |
| Consulting Fee | $6,025 | 3 | 8.6% |
| Compensation for serving as faculty or as a speaker for a medical education program | $2,731 | 1 | 3.9% |
| Honoraria | $2,310 | 1 | 3.3% |
Payments by Type
General
$54,967
479 transactions
Research
$15,006
10 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $17,213 | 33 | $0 (2019) |
| Eli Lilly and Company | $14,035 | 9 | $0 (2023) |
| Medtronic, Inc. | $10,231 | 11 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $6,837 | 23 | $0 (2024) |
| Abbott Laboratories | $6,360 | 10 | $0 (2023) |
| Boston Scientific Corporation | $2,613 | 11 | $0 (2024) |
| W. L. Gore & Associates, Inc. | $2,397 | 3 | $0 (2019) |
| Janssen Research & Development, LLC | $2,245 | 21 | $0 (2023) |
| F. Hoffmann-La Roche AG | $1,337 | 3 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $644.81 | 41 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,275 | 77 | Novartis Pharmaceuticals Corporation ($266.94) |
| 2023 | $9,607 | 93 | Abbott Laboratories ($3,222) |
| 2022 | $11,936 | 42 | AstraZeneca Pharmaceuticals LP ($3,897) |
| 2021 | $18,206 | 30 | Eli Lilly and Company ($11,287) |
| 2020 | $1,364 | 18 | Eli Lilly and Company ($1,072) |
| 2019 | $14,745 | 91 | Medtronic Vascular, Inc. ($11,241) |
| 2018 | $6,334 | 68 | BOSTON SCIENTIFIC CORPORATION ($2,426) |
| 2017 | $6,506 | 70 | Medtronic Vascular, Inc. ($3,640) |
All Payment Transactions
489 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: Neurology | ||||||
| 12/12/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Neurology | ||||||
| 12/10/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Neurology | ||||||
| 12/09/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/12/2024 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Neurology | ||||||
| 11/11/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Neurology | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Neurology | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $1.95 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/03/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Neurology | ||||||
| 10/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: NEUROLOGY | ||||||
| 09/30/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $32.17 | General |
| Category: Rare Disease | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/03/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Rare Disease | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Neurology | ||||||
| 08/20/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Neurology | ||||||
| 08/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: PAIN | ||||||
| 08/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $1.50 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Neurology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ASSESSMENT OF SAFETY, TOLERABILITY AND EFFICACY OF LY3002813 ALONE AND IN COMBINATION WITH LY3202626 IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE | Eli Lilly and Company | $12,135 | 3 |
| ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF DONANEMAB IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE | Eli Lilly and Company | $1,250 | 3 |
| Stroke AF | Medtronic Vascular, Inc. | $970.90 | 1 |
| DONANEMAB FOLLOW-ON STUDY: SAFETY, TOLERABILITY, AND EFFICACY IN SYMPTOMATIC ALZHEIMER'S DISEASE WITH VALIDATION OF REMOTE NEUROPSYCHOLOGICAL ASSESSMENTS | Eli Lilly and Company | $450.00 | 1 |
| A STUDY OF DONANEMAB (LY3002813) IN PARTICIPANTS WITH EARLY ALZHEIMER'S DISEASE (TRAILBLAZER-ALZ 2) | Eli Lilly and Company | $150.00 | 1 |
| DONANEMAB FOLLOW-ON STUDY: SAFETY TOLERABILITY AND EFFICACY IN SYMPTOMATIC ALZHEIMER'S DISEASE WITH VALIDATION OF REMOTE NEUROPSYCHOLOGICAL ASSESSMENTS | Eli Lilly and Company | $50.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 606 | 706 | $242,675 | $66,517 |
| 2022 | 14 | 635 | 774 | $281,754 | $74,413 |
| 2021 | 13 | 685 | 830 | $259,048 | $71,403 |
| 2020 | 15 | 852 | 1,035 | $322,245 | $86,526 |
Total Patients
2,778
Total Services
3,345
Medicare Billing
$298,859
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 56 | 102 | $68,850 | $16,369 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 99 | 110 | $28,600 | $9,254 | 32.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 88 | 92 | $23,920 | $8,048 | 33.6% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 24 | 24 | $34,200 | $7,560 | 22.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 72 | 103 | $18,540 | $6,171 | 33.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $19,355 | $5,870 | 30.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 32 | 35 | $12,250 | $4,597 | 37.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 97 | 99 | $12,870 | $2,676 | 20.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 28 | 28 | $7,420 | $2,417 | 32.6% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 21 | 21 | $8,400 | $1,673 | 19.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 24 | 27 | $3,870 | $1,017 | 26.3% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 16 | 16 | $4,400 | $864.34 | 19.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 63 | 138 | $93,150 | $23,002 | 24.7% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 32 | 32 | $45,600 | $10,882 | 23.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 106 | 113 | $29,380 | $8,709 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 84 | $21,840 | $7,984 | 36.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 79 | 109 | $19,620 | $5,954 | 30.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 42 | 42 | $16,590 | $4,696 | 28.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 29 | 29 | $10,150 | $3,364 | 33.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2022 | 101 | 102 | $13,260 | $2,981 | 22.5% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 19 | 20 | $5,200 | $1,552 | 29.8% |
| 70553 | Mri scan of brain before and after contrast | Office | 2022 | 20 | 20 | $8,000 | $1,544 | 19.3% |
| 93886 | Complete ultrasound of within the brain blood flow | Facility | 2022 | 20 | 36 | $9,324 | $1,292 | 13.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 16 | 16 | $4,240 | $1,288 | 30.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 20 | 21 | $2,100 | $627.18 | 29.9% |
About Dr. Pramodkumar Sethi, M.D
Dr. Pramodkumar Sethi, M.D is a Neurology healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972560894.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pramodkumar Sethi, M.D has received a total of $69,973 in payments from pharmaceutical and medical device companies, with $1,275 received in 2024. These payments were reported across 489 transactions from 72 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($25,496).
As a Medicare-enrolled provider, Sethi has provided services to 2,778 Medicare beneficiaries, totaling 3,345 services with total Medicare billing of $298,859. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Diagnostic Neuroimaging
- Location Greensboro, NC
- Active Since 04/26/2006
- Last Updated 06/08/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1972560894
Products in Payments
- BRILINTA (Drug) $6,735
- Reveal LINQ (Device) $3,837
- AMPLATZER TALISMAN (Device) $3,222
- MITRACLIP (Device) $2,846
- WATCHMAN (Device) $2,436
- CARDIOFORM Septal Occluder (Device) $2,397
- Non-Covered Product (Drug) $1,337
- KESIMPTA (Drug) $317.89
- Aimovig (Biological) $291.26
- INGREZZA (Drug) $267.85
- BOTOX (Biological) $249.85
- Solitaire (Device) $248.88
- QULIPTA (Drug) $193.95
- VUMERITY (Drug) $171.19
- AMPLATZER (Device) $167.73
- Repatha (Biological) $149.85
- NUPLAZID (Drug) $148.17
- WATCHMAN DEVICE (Device) $147.97
- ACTHAR (Biological) $145.67
- LEQVIO (Drug) $138.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Greensboro
Dr. Carmen Dohmeier, M.d, M.D
Neurology — Payments: $14,830
Neurology $14,830
Yijun Yan, Md, MD
Neurology — Payments: $12,473
Neurology $12,473
Dr. Adam Jaffe, D.o, D.O
Neurology — Payments: $10,635
Neurology $10,635
Saima Athar, M.d, Phd, M.D, PHD
Neurology — Payments: $9,443
Neurology $9,443
Karen Aquino, M.d, M.D
Neurology — Payments: $9,199
Neurology $9,199
Dr. Jindong Xu, Md, MD
Neurology — Payments: $8,447
Neurology $8,447